211 related articles for article (PubMed ID: 28731140)
41. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.
Yamazaki J; Jelinek J; Lu Y; Cesaroni M; Madzo J; Neumann F; He R; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Kantarjian HM; Liang S; Estecio MR; Godley LA; Issa JP
Cancer Res; 2015 Jul; 75(14):2833-43. PubMed ID: 25972343
[TBL] [Abstract][Full Text] [Related]
42. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
43. Identification of epigenetically altered genes and potential gene targets in melanoma using bioinformatic methods.
Duan H; Jiang K; Wei D; Zhang L; Cheng D; Lv M; Xu Y; He A
Onco Targets Ther; 2018; 11():9-15. PubMed ID: 29302192
[TBL] [Abstract][Full Text] [Related]
44. Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis.
Wei S; Liu J; Shi Y; Zhang X; Yang Y; Song Q
Mol Med Rep; 2017 Sep; 16(3):3155-3160. PubMed ID: 28713952
[TBL] [Abstract][Full Text] [Related]
45. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
46. TET2 mutation in diffuse large B-cell lymphoma.
Kubuki Y; Yamaji T; Hidaka T; Kameda T; Shide K; Sekine M; Kamiunten A; Akizuki K; Shimoda H; Tahira Y; Nakamura K; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Kitanaka A; Shimoda K
J Clin Exp Hematop; 2017; 56(3):145-149. PubMed ID: 28331128
[TBL] [Abstract][Full Text] [Related]
47. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
48. Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma.
Wang JY; Lao J; Luo Y; Guo JJ; Cheng H; Zhang HY; Yao J; Ma XP; Wang B
Int J Gen Med; 2021; 14():9419-9431. PubMed ID: 34908869
[TBL] [Abstract][Full Text] [Related]
49. Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.
Cao B; Guo X; Huang L; Wang B; Wang W; Han D; Zhang W; Zhong K
Aging (Albany NY); 2021 Jul; 13(13):17768-17788. PubMed ID: 34252883
[TBL] [Abstract][Full Text] [Related]
50. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
51. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
52. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
53. Identification of hub-methylated differentially expressed genes in patients with gestational diabetes mellitus by multi-omic WGCNA basing epigenome-wide and transcriptome-wide profiling.
Chen M; Yan J; Han Q; Luo J; Zhang Q
J Cell Biochem; 2020 Jun; 121(5-6):3173-3184. PubMed ID: 31886571
[TBL] [Abstract][Full Text] [Related]
54. Genome‑wide DNA methylation profile of thymomas and potential epigenetic regulation of thymoma subtypes.
Bi Y; Meng Y; Niu Y; Li S; Liu H; He J; Zhang Y; Liang N; Liu L; Mao X; Yan J; Long B; Liang Z; Wu Z
Oncol Rep; 2019 May; 41(5):2762-2774. PubMed ID: 30816514
[TBL] [Abstract][Full Text] [Related]
55. Potential biomarkers of HCC based on gene expression and DNA methylation profiles.
Meng C; Shen X; Jiang W
Oncol Lett; 2018 Sep; 16(3):3183-3192. PubMed ID: 30127913
[TBL] [Abstract][Full Text] [Related]
56. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
[TBL] [Abstract][Full Text] [Related]
57. Identification of target gene of venous thromboembolism in patients with lymphoma via microarray analysis.
Liu P; Jiang W; Zhang H
Oncol Lett; 2017 Sep; 14(3):3313-3318. PubMed ID: 28927082
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
59. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
60. Prediction of crucial epigenetically‑associated, differentially expressed genes by integrated bioinformatics analysis and the identification of S100A9 as a novel biomarker in psoriasis.
Wang X; Liu X; Liu N; Chen H
Int J Mol Med; 2020 Jan; 45(1):93-102. PubMed ID: 31746348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
